How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

630 results for

Emergency Medicine Treatment and Labor Act

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Health Insurance Portability and Accountability Act

Health Insurance Portability and Accountability Act Health Insurance Portability and Accountability Act - Wikipedia Health Insurance Portability and Accountability Act From Wikipedia, the free encyclopedia Health Insurance Portability and Accountability Act of 1996 Other short titles Kassebaum–Kennedy Act, Kennedy–Kassebaum Act Long title An Act To amend the Internal Revenue Code of 1986 to improve portability and continuity of health insurance coverage in the group and individual markets (...) ( , in lieu of ) Reported by the joint conference committee on July 31, 1996; agreed to by the House on August 1, 1996 ( ) and by the Senate on August 2, 1996 ( ) Signed into law by President on August 21, 1996 The Health Insurance Portability and Accountability Act of 1996 ( HIPAA ; , 110 , enacted August 21, 1996) was enacted by the and signed by President in 1996. It was created primarily to modernize the flow of healthcare information, stipulate how Personally Identifiable Information maintained

Full Text available with Trip Pro

2012 Wikipedia

102. Lyme disease

disease 26 Clinical assessment 27 Laboratory investigations 28 Emergency referral and specialist advice 29 Antibiotic treatment 30 Ongoing symptoms after a course of antibiotics 37 Non-antibiotic management of ongoing symptoms 38 Management for women with Lyme disease during pregnancy and their babies 38 Information for people with Lyme disease 39 Context 41 Finding more information and resources 43 Lyme disease (NG95) © NICE 2019. All rights reserved. Subject to Notice of rights (https (...) rationale and impact. Labor Laboratory in atory inv vestigations to support diagnosis estigations to support diagnosis NICE has also produced a visual summary of the recommendations on testing for Lyme disease. 1.2.11 Diagnose and treat Lyme disease without laboratory testing in people with erythema migrans. 1.2.12 Use a combination of clinical presentation and laboratory testing to guide diagnosis and treatment in people without erythema migrans. Do not rule out diagnosis if tests are negative

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

103. Treatment and recommendations for homeless people with asthma

Health Care for the Homeless projects are funded by the Bureau of Primary Health Care in the Health Resources and Services Administration of the U.S. Department of Health and Human Services under Section 330(h) of the Public Health Services Act. ADAPTING YOUR PRACTICE: Treatment and Recommendations for Homeless Patients with Asthma Health Care for the Homeless Clinicians’ Network iii ACKNOWLEDGEMENTS The HCH Clinicians’ Network appreciates the skillful guidance of Diane Judge, APN/CNP, Family Nurse (...) of Pediatrics at the Albert Einstein College of Medicine in New York City, who reviewed and commented on these recommendations prior to publication. Adapting Your Practice: Treatment and Recommendations for Homeless Patients with Asthma was developed with support from the Health Resources and Services Administration, U.S. Department of Health and Human Services. ADAPTING YOUR PRACTICE: Treatment and Recommendations for Homeless Patients with Asthma Health Care for the Homeless Clinicians’ Network iv Table

2008 National Health Care for the Homeless Council

104. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA

protection, commonly referred to as asylum applicants, are entitled to necessary healthcare, which must include at least emergency care and essential treatment of illness, as well as necessary medical or other assistance for those who have special needs. • Persons granted international protection, namely refugees and subsidiary protection status holders, have equal access to healthcare to that of a Member State national. • Various EU law instruments contain a duty by Member States to address the urgent (...) medical needs of people intercepted or apprehended at the border, including those rescued at sea. • Victims of trafficking in human beings are entitled to necessary medical treatment, including psychological assistance, counselling and information. • People in return procedures are entitled to the same level of healthcare granted to asylum applicants – namely ‘emergency healthcare and essential treatment of illness’ – if they have been given a period for voluntary departure or if their removal

2019 European Centre for Disease Prevention and Control - Public Health Guidance

105. Individualised funding interventions to improve health and social care outcomes for people with a disability

allocation system':ab,ti OR 'self-directed assessment':ab,ti OR 'self-directed care':ab,ti OR 'self-directed support':ab,ti OR 'support plan':ab,ti OR 'virtual budget':ab,ti OR 'disability living allowance':ab,ti OR 'self-determin*':ab,ti AND [1985-2015]/py Grey literature An international list of grey literature databases published by the Campbell Collaboration (Hammerstrøm et al., 2009) was consulted in the first instance. A US electronic database, run by The New York Academy of Medicine and dedicated (...) known as the Local Area Coordination charter which facilitated a mechanism for “Direct Consumer Funding” (Carter Anand et al., 2012b). Thus, individualised funding appears to have emerged for the first time, around the mid-eighties. For this reason, the searches of published literature were limited to the period 1985 – quarter 1 of 2016. For example, date filters were applied to the Scopus search results (Appendix 1). Other filters were also applied where necessary to refine the search

2019 Campbell Collaboration

106. Critical Assessment of Diabetes Guidelines

Critical Assessment of Diabetes Guidelines MED CHECK April 2019/ Vol.5 No.13 · Page C N o 13 M ED HECK A p r i l 2 0 1 9 Accelerated Approval, Ignoring Harm, is a Crime New Direct-acting Antiviral for Hepatitis C (Epclusa ) Hemorrhage caused by an Anti-influenza Agent, Baloxavir Editorial Accelerated Approval, Ignoring Harm, is a Crime New Products New Direct-acting Antiviral for Hepatitis C (Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated cirrhosis Adverse (...) for whom an anti-influenza drug should be effective. However, if you have severe flu symptoms, you may lose appetite and cannot eat. Then, you have to avoid using Xofluza due to the high risk of bleeding. After all, just like Tamiflu, Xofluza has no place in use for influenza infection. Accelerated approval, ignoring harm, is a crime.MED CHECK April 2019/ Vol.5 No.13 · Page New Direct-acting Antiviral for Hepatitis C ( Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated

2019 Med Check - The Informed Prescriber

107. Diagnosis and management of epilepsy in adults

, this guideline was updated to take account of new drug safety advice from the Medicines and Healthcare products Regulatory Agency (MHRA), published in April 2018, relating to use of valproate medicines in women and girls of childbearing potential. 454 Warnings have been inserted where relevant in sections 4 and 5 to reflect this advice. 2 Key recommendations New 3 Diagnosis Updated 4 Treatment Updated September 2018 5 Epilepsy and women’s health Updated September 2018 6 Psychiatric comorbidity New 7 Sleep (...) the diagnostic and treatment choices available. It is advised, however, that significant departures from the national guideline or any local guidelines derived from it should be fully documented in the patient’s case notes at the time the relevant decision is taken. 1.3.1 PRESCRIBING OF LICENSED MEDICINES OUTWITH THEIR MARKETING AUTHORISATION Recommendations within this guideline are based on the best clinical evidence. Some recommendations may be for medicines prescribed outwith the marketing authorisation

2018 SIGN

108. Review of effective strategies to promote breastfeeding

INSTITUTE Executive summary Purpose of the Evidence Check Babies who are not breastfed, and women who don’t breastfeed, are at an increased chance of many health risks in both the short and long term, including in high-income countries such as Australia. 1, 2 Studies in countries such as the US, Britain and Australia have also shown that the economic and health treatment costs of prevailing low rates of breastfeeding are high. Globally, interventions to support breastfeeding are among the most effective (...) ) for low-birthweight infants. 19, 21 Studies from other areas of public health and nutrition, such as tobacco control or food systems, can inform choices about cost-effective approaches to increasing breastfeeding. For example, financial incentives are emerging as an effective strategy for encouraging health-related behaviours (such as smoking cessation among pregnant women). Research published in 2017 shows that offering financial incentives has potential to improve breastfeeding practices

2018 Sax Institute Evidence Check

109. Peripartum Analgesia and Anesthesia for the Breastfeeding Mother

the prenatal period, before the onset of labor. This discussion should include what is known about the association of various modalities on the progress of labor, risk of instrumented and cesarean delivery, effects on the newborn, and possible breastfeeding effects (IV). 1 Department of Anesthesiology, University of California, San Diego, California. 2 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland. 3 Department of Anesthesiology, Columbia University (...) , New York City, New York. 4 Division of Anesthesiology, Pain, and Perioperative Medicine, Children’s National Health System, Washington, District of Columbia. 1 Downloaded by Ucsd Libraries University of California San Diego from www.liebertpub.com at 03/31/18. For personal use only. ABM Protocol 2 ABM PROTOCOL Regardless of the modality used for labor analgesia, comprehensive patient and provider education, early and uninterrupted initiation of maternal–infant skin-to-skin con- tact, continuing

2019 Academy of Breastfeeding Medicine

110. Treating Opioid Use Disorder During Pregnancy: Guideline Supplement

and buprenorphine/naloxone for the treatment of opioid use disorder in pregnancy. 8,9,32-34 It is important to note that, unless clinically indicated, transitioning between methadone, buprenorphine/ naloxone, and slow-release oral morphine is NOT advisable for patients who are stable on one of these agents during pregnancy and postpartum; the process of reducing and titrating medication dosage during transition may result in the re-emergence of withdrawal symptoms and increased risk of relapse. Research has (...) and pharmacological treatment. Neonatal withdrawal is not equivalent to substance use disorder or opioid addiction in infants and can be medically treated (see the Neonatal Opioid Withdrawal Symptoms section). Neonatal methadone withdrawal lasts longer than withdrawal symptoms attributed to shorter acting opioids such as heroin (due to the long half-life of methadone). 9,34 Nevertheless, these symptoms are treatable, and the risks of maternal methadone treatment to the neonate are proven to be far fewer and less

2018 British Columbia Perinatal Health Program

111. The Patient Centred Medical Home: barriers and enablers to implementation

that reward PCMH activities was cited as the main barrier and, correspondingly, payment incentives acted as a facilitator for implementation. For example: • Payment incentives for PCMH emerged as one of the key facilitators for PCMH implementation in a study of small and medium practices 17 • In New Orleans, 62% of primary care safety net clinics responded to payment incentives linked to receiving recognition from the National Committee for Quality Assurance as a PCMH 19 • A correlational study identified (...) relationship with clinicians treating patients, and patients and their family members. • Dedicated care coordination roles • Located within doctor’s office. 12 THE PATIENT CENTRED MEDICAL HOME: BARRIERS AND ENABLERS TO IMPLEMENTATION | SAX INSTITUTE Component of change and why it’s important Barriers/challenges Enablers Care coordination beyond the practice: Supports effective management of patients and transition between emergency department/hospital and primary care. • Continued reliance on paper-based

2018 Sax Institute Evidence Check

112. Heart Disease and Stroke Statistics

None Marcio S. Bittencourt University of Sao Paulo Sanofi None None None None None None Clifton W. Callaway University of Pittsburgh, Department of Emergency Medicine April P. Carson University of Alabama at Birmingham, Department of Epidemiology Centers for Disease Control and Prevention ; National Heart, Lung, and Blood Institute ; National Institute for Diabetes and Digestive and Kidney Diseases ; Amgen, Inc None None None None None None Alanna M. Chamberlain Mayo Clinic Health Sciences Research (...) , and Treatment of High Blood Pressure. In prospective follow-up of the REGARDS, MESA (Multi-Ethnic Study of Atherosclerosis), and JHS (Jackson Heart Study) cohorts, 63.0% of incident CVD events occurred in participants with systolic BP (SBP) <140 mm Hg and diastolic BP <90 mm Hg. US non-Hispanic (NH) blacks (13.2%) are more likely than NH Asians (11.0%), NH whites (8.6%), or Hispanics (7.4%) to use home BP monitoring on a weekly basis. In 2015, the worldwide prevalence of SBP ≥140 mm Hg was estimated

Full Text available with Trip Pro

2019 American Heart Association

113. AIM Clinical Appropriateness Guidelines for Joint Surgery

is a surgical procedure in which a small fiberoptic camera is inserted into the joint through a small incision. In addition to allowing the surgeon to visualize the joint, arthroscopy may also be utilized for treatment of a variety of conditions involving the joint structures. This document addresses shoulder arthroscopy and open procedures when performed as an elective, non-emergent procedure and not as part of the care of an acute fracture. General requirements The provider shall submit a detailed (...) , Zhang DH, Peng XC, et al. Comparison of Surgical versus Non-Surgical Treatment of Displaced 3- and 4-Part Fractures of the Proximal Humerus: A Meta-Analysis. Journal of investigative surgery : the official journal of the Academy of Surgical Research. 2015;28(4):215-24. 9. University of New South Wales HK, Clinical practice guidelines for the management of rotator cuff syndrome in the workplace, (2013) Port Macquarie Australia, 80. 10. Washington State Department of Labor and Industries, Shoulder

2019 AIM Specialty Health

114. Nifedipine

to 7.2 mm Hg], diastolic: 3.3 mm Hg [-0.6 to 7.3 mm Hg]). Mean blood pressure was 134/84 mm Hg 2017 4. Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor - Full Text View - ClinicalTrials.gov Example: "Heart attack" AND "Los Angeles" Search for studies: IMPORTANT : Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare (...) professional before volunteering for a study. Study Record Detail Nifedipine or Nifedipine Plus (...) View Purpose Tocolytic agents are used for the treatment of preterm labor. It is unclear whether combination treatments of two tocolytic agents are more effective in stopping preterm labor compared to one. Therefore, the investigators propose a comparative effective trial of nifedipine plus indomethacin vs. nifedipine alone for the treatment of preterm labor Preterm Labor Drug: Nifedipine Drug

2018 Trip Latest and Greatest

115. Management of Cardiovascular Diseases during Pregnancy

mobile search navigation Article navigation 07 September 2018 Article Contents Article Navigation 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Vera Regitz-Zagrosek Chairperson Corresponding authors. Vera Regitz-Zagrosek, Charité Universitaetsmedizin Berlin, Institute for Gender in Medicine, CCR, DZHK, partner site Berlin, Hessische Str 3-4, 10115 Berlin, Germany, Tel: +49 30 450 525 288, Fax: +49 30 450 7 525 288, E-mail: . Search for other works by this author (...) Navbar Search Filter Mobile Microsite Search Term Close search filter search input , , , , , , , , , , , , , , The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Endorsed by: the International Society of Gender Medicine (IGM), the German Institute of Gender in Medicine (DGesGM), the European Society of Anaesthesiology (ESA), and the European Society of Gynecology (ESG) Table of Contents Table of Contents 3166 List of tables 3168

Full Text available with Trip Pro

2018 European Society of Cardiology

116. Pneumonia induced by benzodiazepines

mongering Medical checkups create “patients” and shorten their lifespan by “treatment” Adverse Reactions Pneumonia induced by benzodiazepines Evidence shows causal relations CONTENTS (August 2018, Vol. 4, No. 11 ) 16 17 20 24 Volume 4 Page 16 · MED CHECK - TIP August 2018/ Vol.4 No.11 What we learned from epidemiological studies on drug-induced pneumonia It is well known that corticosteroids and cytotoxic anticancer agents cause infections. The labels of non- steroidal anti-inflammatory drugs (NSAIDs (...) was confirmed ( p.24). Some other sleeping pills such as svorexant (orexin antagonist: MedCheckTIP No. 74 or English edition No. 9) and ramelteon (melatonin agonist: ibid No. 75) also have immunosuppressive effect and increase infectious diseases. We have learned the followings from the epidemiological survey which showed strong association between sleeping pills and CAP: First, drugs that act on the basic mechanism of the body, such as proton pumps and benzodiazepine receptors, have immunosuppressive

2018 Med Check - The Informed Prescriber

117. Do general health checks prolong lifespan?

is precisely elucidated, many receptors and their ligands (substances acting on receptors) are discovered, and numerous potential new drugs are developed. Since 2000, many clinical practice guidelines have been published in Japan as well. They are claimed to Who benefits from the guidelines? Translated from the Editorial in the issue 75 (Jan. 2018) as the introduction of the series: Critical appraisal of the Japanese “Practice Guidelines” have been created in accordance with the Evidence-Based Medicine (...) Source: Based on a hierarchy from Levels of Evidence and Grades of Recommendation by Centre for Evidence-Based Medicine, Institute of Health Sciences, Oxford [www.cebm.net/levels_of_evidence.asp#notes] *a: All or none case-series (i.e. when all patients died before the treatment became available, but some now survive on it; or when some patients died before treatment became available, but none now die on it, are classified as 1c). Box 8.1 Strength of endpoints (ranked in descending order) Source

2018 Med Check - The Informed Prescriber

118. Prepregnancy counseling

for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Practice Committee of American Society for Reproductive Medicine. Fertil Steril 2013;99:340–6. yy Preexposure prophylaxis for the prevention of human immunode?ciency virus. Committee Opinion No. 595. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;123:1133–6. zz Inherited thrombophilias in pregnancy. Practice Bulletin No. 138. American College (...) Prepregnancy counseling Prepregnancy counseling Committee Opinion No. 762 American Society for Reproductive Medicine and American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice American Society for Reproductive Medicine, Birmingham, Alabama; and American College of Obstetricians and Gynecologists, Washington, D.C. The goalof prepregnancycare istoreduce the risk ofadverse health effectsfor thewoman,fetus,and neonate byworkingwiththe woman to optimize health

2019 Society for Assisted Reproductive Technology

119. Interpregnancy Care

Interpregnancy Care Interpregnancy Care - ACOG Menu ▼ Interpregnancy Care Page Navigation ▼ Number 8 This document is endorsed by the American College of Nurse-Midwives and the National Association of Nurse Practitioners in Women’s Health. This document was developed by the American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine in collaboration with Judette Marie Louis MD, MPH; Allison Bryant, MD, MPH; Diana Ramos, MD, MPH; Alison Stuebe, MD, MSc (...) ; and Sean C. Blackwell, MD. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment

2019 American College of Obstetricians and Gynecologists

120. Clinical Practice Guideline for the Management of Infantile Hemangiomas

for harms of interventions. Sleep disturbance, sleeping disorders, agitation during the night, and nightmares or night terrors were mentioned in 6 of 8 reports and occurred in 2% to 18.5% of patients who were treated. , , , , , In 3 of these 6 reports, propranolol treatment was modified (reduction in dosage, earlier-evening dosing, and early discontinuation of therapy) in response to these effects. , , In 4 reports, possible respiratory adverse effects were mentioned, including labored breathing in 0.9 (...) benign tumor of infancy. Most IHs are small, innocuous, self-resolving, and require no treatment. However, because of their size or location, a significant minority of IHs are potentially problematic. These include IHs that may cause permanent scarring and disfigurement (eg, facial IHs), hepatic or airway IHs, and IHs with the potential for functional impairment (eg, periorbital IHs), ulceration (that may cause pain or scarring), and associated underlying abnormalities (eg, intracranial and aortic

2019 American Academy of Pediatrics

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>